Get startedLog in
    Picture of Sumitomo Pharma logo

    4506 — Sumitomo Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapValue Trap
    All News

    To Post Impairment Loss Of 54.37 Billion Yen In Q2 Associated With Underperforming Treatment Kynmobi

    Picture of Sumitomo Pharma logoSumitomo Pharma
    06/10/2022 07:06
    Oct 6 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * TO POST IMPAIRMENT LOSS OF 54.37 BILLION YEN ($376.21
million)
IN Q2 ASSOCIATED WITH UNDERPERFORMING TREATMENT KYNMOBI

Source text for Eikon:  ID:nTSvf8430f 
Further company coverage:  4506.T 
($1 = 144.5200 yen)

    Recent news on Sumitomo Pharma

    See all news